Clinical Trials on High-Risk and Oligometastatic Prostate Cancer in United Kingdom
Total 3553 results
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Won KimNovartisTerminated
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
University of FloridaCompleted
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedProstate Cancer | Prostate Adenocarcinoma | High Risk Prostate CancerUnited States
-
VA Office of Research and DevelopmentRecruiting
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Ivan de Kouchkovsky, MDNot yet recruitingProstate Cancer | High Risk Prostate CarcinomaUnited States
-
Prisma Health-UpstateRecruiting
-
The Methodist Hospital Research InstituteCompleted
-
Rana McKay, MDUniversity of California, San Diego; AstraZenecaRecruitingProstate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Adenocarcinoma | High-Risk CancerUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
Catherine SpinaArcus Biosciences, Inc.RecruitingOligometastatic Prostate CancerUnited States
-
VA Office of Research and DevelopmentCompletedNewly Diagnosed Oligometastatic Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
Dana-Farber Cancer InstituteMedivation, Inc.Completed
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
University of Michigan Rogel Cancer CenterRecruitingProstate Cancer | Oligometastatic Disease | Castrate Sensitive Prostate CancerUnited States
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
DendreonCompletedProstate Cancer | Prostate Neoplasms | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Cancer of ProstateAustria, France, Netherlands, United Kingdom
-
Henry Ford Health SystemAmerican Cancer Society, Inc.WithdrawnLow or Intermediate Risk Prostate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomProstate Cancer UKRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterCompletedCancer Survivors | Statin Use Among High Risk SurvivorsUnited States
-
Jonsson Comprehensive Cancer CenterPOINT BiopharmaActive, not recruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate AdenocarcinomaUnited States
-
Angle plcMidLantic Urology, LLCTerminatedProstate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate CarcinomaUnited States
-
University College London HospitalsCompleted
-
University College, LondonKing's College London; Imperial College London; Medical Research Council; Cancer...Completed
-
Barts & The London NHS TrustTerminatedCastrate Resistant Prostate CancerUnited Kingdom
-
University College, LondonRecruitingProstate Cancer | Prostate NeoplasmUnited Kingdom
-
Queen's University, BelfastHSC Public Health AgencyCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited Kingdom
-
University of Maryland, BaltimoreRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
The Christie NHS Foundation TrustAstraZenecaCompletedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Genesis Research LLCRecruitingProstate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance RegimenUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeSuspendedProstate Cancer | Prostate NeoplasmUnited Kingdom
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLCRecruitingCastration-resistant Prostate CancerUnited Kingdom
-
Imperial College LondonWellcome Trust; Imperial Clinical Trials Unit (ICTU)CompletedProstate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Metastatic Prostate Carcinoma in the Soft Tissue | Non-metastatic Prostate CancerUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
Guy's and St Thomas' NHS Foundation TrustActive, not recruiting
-
Mayo ClinicRecruitingBiochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate AdenocarcinomaUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...Active, not recruiting
-
University College London HospitalsUnknownProgression of Prostate CancerUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUnknownProstate Cancer | Prostate BiopsyUnited Kingdom
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateNetherlands, United States, United Kingdom
-
Mayo ClinicNot yet recruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount SinaiActive, not recruitingLow Risk Prostate CancerUnited States